# Oxford Finance LLC's Biotech Investments: 12 Startups in Its Portfolio (2026) > The 12 Biotech startups Oxford Finance LLC has backed, by stage: $1.1B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/oxford-finance-llc-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 5 - [Intuity Medical](https://millionrounds.com/company/intuity-medical) - [*VC* Venus Concept](https://millionrounds.com/company/venus-concept) - [Intellicyt](https://millionrounds.com/company/intellicyt) - [*I* InterValve](https://millionrounds.com/company/intervalve) - [*EP* Edgemont Pharmaceuticals](https://millionrounds.com/company/edgemont-pharmaceuticals) ## Series C and later 5 - [Sonendo](https://millionrounds.com/company/sonendo) - [*B* BioVex](https://millionrounds.com/company/biovex) - [Singulex](https://millionrounds.com/company/singulex) - [Monteris Medical](https://millionrounds.com/company/monteris-medical) - [*CT* Ceptaris Therapeutics](https://millionrounds.com/company/ceptaris-therapeutics) ## Series B 2 - [Tarsa Therapeutics](https://millionrounds.com/company/tarsa-therapeutics) - [Conventus Orthopaedics](https://millionrounds.com/company/conventus-orthopaedics) ## Segment by segment ### Stage not reported 5 startups · $389M raised - [**Intuity Medical**](https://millionrounds.com/company/intuity-medical) Intuity Medical develops blood glucose monitoring systems for diabetes management. United States $275M - [*VC* **Venus Concept**](https://millionrounds.com/company/venus-concept) Canada $70M - [**Intellicyt**](https://millionrounds.com/company/intellicyt) IntelliCyt Corporation develops and markets high-throughput cell and bead-based screening solutions for the use of life sciences. United States $25M - [*I* **InterValve**](https://millionrounds.com/company/intervalve) InterValve develops medical devices and technology for the catheter-based treatment of calcified aortic valve stenosis. United States $14M - [*EP* **Edgemont Pharmaceuticals**](https://millionrounds.com/company/edgemont-pharmaceuticals) Edgemont Pharmaceuticals focuses on the field of neuroscience and develops novel drug formulations and therapies to improve patient care. United States $4.8M ### Series C and later 5 startups · $536M raised - [**Sonendo**](https://millionrounds.com/company/sonendo) Sonendo is a healthcare company that focuses on developing innovative and disruptive technologies to transform endodontic therapy. United States $146M - [*B* **BioVex**](https://millionrounds.com/company/biovex) THOUSAND OAKS, Calif., March 4, 2011 /PRNewswire via COMTEX/ -- Amgen (Nasdaq: AMGN), today announced the completion of the acquis United Kingdom $133M - [**Singulex**](https://millionrounds.com/company/singulex) Singulex develops direct molecular detection technology, cardiovascular monitoring, and related solutions to understand and manage diseases. United States $127M - [**Monteris Medical**](https://millionrounds.com/company/monteris-medical) Monteris Medical is a privately held company based in Minnetonka, Minnesota, focused on developing minimally invasive solutions fo United States $104M - [*CT* **Ceptaris Therapeutics**](https://millionrounds.com/company/ceptaris-therapeutics) Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides. United States $25M ### Series B 2 startups · $215M raised - [**Tarsa Therapeutics**](https://millionrounds.com/company/tarsa-therapeutics) Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis. United States $121M - [**Conventus Orthopaedics**](https://millionrounds.com/company/conventus-orthopaedics) Conventus Orthopaedics is a provider of a range of orthopedic and sports medicine services. United States $94M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Oxford Finance LLC as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio)[Sector portfolio **Pioneer Fund's AI portfolio** 171 startups · $2.8B](https://millionrounds.com/portfolio-maps/pioneer-fund-2-ai-portfolio)[Sector portfolio **Gaingels' AI portfolio** 146 startups · $14B](https://millionrounds.com/portfolio-maps/gaingels-ai-portfolio)[Sector portfolio **Cormorant Asset Management's Biotech portfolio** 95 startups · $21B](https://millionrounds.com/portfolio-maps/cormorant-asset-management-biotech-portfolio)[Sector portfolio **Goldman Sachs' Fintech portfolio** 85 startups · $20B](https://millionrounds.com/portfolio-maps/goldman-sachs-fintech-portfolio) ## Raising from investors like Oxford Finance LLC? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)